CN211871932U - In-vitro diagnosis and analysis device and reagent card - Google Patents
In-vitro diagnosis and analysis device and reagent card Download PDFInfo
- Publication number
- CN211871932U CN211871932U CN201922159498.7U CN201922159498U CN211871932U CN 211871932 U CN211871932 U CN 211871932U CN 201922159498 U CN201922159498 U CN 201922159498U CN 211871932 U CN211871932 U CN 211871932U
- Authority
- CN
- China
- Prior art keywords
- hole
- interface
- communicated
- reaction chamber
- reagent card
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The utility model discloses an external diagnostic analysis device and reagent card, this reagent card include first body, first body is including advancing kind interface, lysate interface, first gas pocket and the first reaction chamber of connecing, advance kind interface the schizolysis interface and first gas pocket of connecing respectively with first reaction chamber intercommunication, first reaction chamber is equipped with first liquid end, first liquid end with first gas pocket staggers. The in-vitro diagnosis and analysis device and the reagent card can perform cracking extraction of sample liquid, and reduce the labor intensity of nucleic acid extraction.
Description
Technical Field
The utility model relates to the technical field of medical equipment, in particular to an in vitro diagnosis and analysis device and a reagent card.
Background
An in vitro diagnostic and analytical device is an instrument that allows quantitative or qualitative analysis of a sample of a patient's body fluid.
In the field of biotechnology, nucleic acid extraction using a magnetic particle method generally requires steps such as lysis, binding, washing, elution, and the like, and detection steps such as subsequent nucleic acid molecule hybridization, Polymerase Chain Reaction (PCR), biochip, and the like, so that nucleic acid extraction and analysis are difficult to be realized in a conventional analyzer. And the traditional manual transfer mode is adopted, so that the operation is complex, time-consuming and labor-consuming.
SUMMERY OF THE UTILITY MODEL
Accordingly, there is a need for an in vitro diagnostic and analytical apparatus and a reagent card that can perform lysis extraction of a sample solution and reduce labor intensity for nucleic acid extraction.
The technical scheme is as follows:
in one aspect, the application provides a reagent card, including first body, first body including advance kind interface, lysate interface, first connect gas pocket and first reaction chamber, advance kind interface the schizolysis interface and first connect the gas pocket respectively with first reaction chamber intercommunication, first reaction chamber is equipped with out the liquid end, go out the liquid end with first connect the gas pocket to stagger.
When the reagent card is used, the sample introduction interface is communicated with a reagent bag filled with sample liquid, and then the first air receiving hole is butted by using an air pump, so that the sample liquid can be pumped into the first reaction cavity; the lysate interface is communicated with a reagent bag filled with lysate, so that the lysate can be pushed into the first reaction cavity, and the sample solution can be cracked to obtain a first extracting solution (in the process, the cracking of the sample solution can be accelerated by using a heating element or an ultrasonic generator). In the process, manual intervention can be reduced, and the labor intensity of nucleic acid extraction is reduced. And the reagent card is used for cracking and extracting the sample liquid, so that the sample liquid is prevented from being polluted due to improper manual operation.
The technical solution is further explained below:
in one embodiment, the reagent card further comprises a second body, the second body comprises a second reaction cavity, the second reaction cavity is communicated with the first liquid outlet end, the second reaction cavity is provided with a second air receiving hole and a second liquid outlet end, and the second liquid outlet end is staggered with the second air receiving hole.
In one embodiment, the second body further comprises a binding liquid interface, and the binding liquid interface is communicated with the second reaction cavity.
In one embodiment, the binding liquid interface is communicated with the second reaction chamber through a first flow channel, and the first flow channel is provided with a magnetic particle interface.
In one embodiment, the reagent card further comprises a storage part movably connected with the magnetic particle interface, wherein the storage part is provided with a storage cavity for storing magnetic particles, and a through hole communicated with the storage cavity; when the storage part is at the first position, the through hole is not communicated with the first flow passage; when the storage member is in the first position, the through hole communicates with the first flow passage.
In one embodiment, the second body further comprises a cleaning solution interface, and the cleaning solution interface is communicated with the second reaction chamber.
In one embodiment, the second body further comprises an eluent interface in communication with the second reaction chamber.
In one embodiment, the reagent card further comprises a first control valve assembly, wherein the first control valve assembly is used for respectively controlling the connection and disconnection of the sample inlet interface and the first reaction cavity, the connection and disconnection of the lysate interface and the first reaction cavity, the connection and disconnection of the second reaction cavity and the first liquid outlet end, the connection and disconnection of the second reaction cavity and the binding liquid interface, the connection and disconnection of the second reaction cavity and the cleaning liquid interface, and the connection and disconnection of the second reaction cavity and the eluent interface.
In one embodiment, the first control valve assembly includes a first valve seat and a first valve core movably disposed on the first valve seat, the first valve seat is disposed on the first body or/and the second body, and the first valve seat is respectively communicated with the sample inlet interface, the lysate interface, the binding solution interface, the cleaning solution interface, the eluent interface, the first reaction chamber and the second reaction chamber, and the first valve core is provided with a first channel and a second channel;
when the first valve core is at a first position, only the sample inlet interface is communicated with the first reaction cavity through the first channel;
when the first valve core is at the second position, only the lysate interface is communicated with the first reaction cavity through the first channel;
when the first valve core is at a third position, only the second reaction cavity is communicated with the first liquid outlet end through the second channel;
when the first valve core is at the fourth position, only the bonding liquid interface is communicated with the second reaction cavity through the first channel;
when the first valve core is at a fifth position, only the cleaning liquid interface is communicated with the second reaction cavity through the first channel;
when the first valve core is at the sixth position, only the eluent interface is communicated with the second reaction cavity through the first channel.
In one embodiment, the reagent card further comprises a second control valve, the second control valve is provided with a second valve seat and a second valve core movably arranged in the second valve seat, the second valve seat is provided with a first through hole communicated with the first liquid outlet end, the binding liquid interface, the cleaning liquid interface and the eluent interface, and a second through hole communicated with the second liquid outlet end, and the second valve core is provided with a third channel communicated with the first through hole and the second through hole.
In one embodiment, the reagent card further comprises a waste liquid cavity, the waste liquid cavity is provided with an exhaust hole, the second valve seat is provided with a third through hole communicated with the waste liquid cavity, and the second valve core is provided with a fourth channel for communicating the third through hole and the second through hole;
when the second spool is in a seventh position, only the first through hole communicates with the second through hole through the third passage;
when the second spool is in the eighth position, only the third through-hole communicates with the second through-hole through the fourth passage.
In one embodiment, the reagent card further comprises a third body, the third body is provided with a freeze-dried bead storage cavity and a mixing cavity communicated with the freeze-dried bead storage cavity, the freeze-dried bead storage cavity is communicated with the second liquid outlet end, and the mixing cavity is provided with a third air receiving hole.
In one embodiment, the second valve seat is provided with a fourth through hole communicated with the freeze-dried bead storage chamber, and the second valve core is provided with a fifth channel for communicating the fourth through hole and the second through hole;
when the second spool is in the ninth position, only the fourth through-hole communicates with the second through-hole through the fifth passage.
In one embodiment, the reagent card further comprises a fourth body, wherein the fourth body is provided with a detection cavity, and the detection cavity is communicated with the liquid outlet end of the mixing cavity.
In one embodiment, the detection cavity comprises four PCR cavities, and the four PCR cavities are communicated with the liquid outlet end of the mixing cavity through a rotary valve.
On the other hand, the application also provides an in vitro diagnosis and analysis device, which comprises a reagent card and an air pump, wherein the connecting end of the air pump is connected with the first air receiving hole.
When the in-vitro diagnosis and analysis device is used, the reagent card is connected with the reagent bag, and then the reagent card is inserted into a preset position. At the moment, the air pump acts to pump the sample liquid into the first reaction cavity, and the lysate is pushed into the first reaction cavity so that the sample liquid can be lysed to obtain a first extracting solution. The in vitro diagnosis and analysis device can perform cracking extraction of sample liquid, and is favorable for reducing the labor intensity of nucleic acid extraction.
The technical solution is further explained below:
in one embodiment, the in-vitro diagnostic and analysis device further comprises a heating element, wherein the heating element is arranged outside the first reaction cavity; and the ultrasonic generator is arranged outside the first reaction cavity.
In one embodiment, the reagent card is provided with a second reaction cavity, the second reaction cavity is communicated with the first liquid outlet end, and the second reaction cavity is provided with a second air receiving hole and a second liquid outlet end; the in-vitro diagnosis and analysis device further comprises an adsorption element, the adsorption element is arranged on the outer side of the second reaction cavity, and the connecting end of the air pump can be connected with the second air receiving hole.
Drawings
FIG. 1 is a schematic diagram of an assembly structure of a reagent card and a reagent pack according to an embodiment;
FIG. 2 is a schematic half-section view of the reagent pack shown in FIG. 1;
FIG. 3 is a schematic diagram of the internal structure of a reagent card and a reagent pack according to an embodiment;
FIG. 4 is a schematic illustration of the configuration of FIG. 3 with the first spool in a first position;
FIG. 5 is a schematic illustration of the configuration of FIG. 3 with the first valve spool in a second position;
FIG. 6 is a schematic illustration of the first valve spool in a third position in the configuration of FIG. 3;
FIG. 7 is a schematic illustration of the configuration of FIG. 3 with the first spool in a fourth position (and the second spool in a seventh position);
FIG. 8 is a schematic illustration of the configuration of FIG. 3 with the first spool in a fifth position (and the second spool in a seventh position);
FIG. 9 is a schematic illustration of the configuration of FIG. 3 with the first spool in a sixth position (with the second spool in a seventh position);
FIG. 10 is a cross-sectional schematic view of the first control valve assembly shown in FIG. 3;
FIG. 11 is a schematic view of the second spool in an eighth position in the configuration of FIG. 3;
FIG. 12 is a schematic view of the second spool in a ninth position in the configuration of FIG. 3;
FIG. 13 is a cross-sectional schematic view of the second control valve assembly shown in FIG. 3;
FIG. 14 is a schematic view of the mixing chamber in communication with the sensing chamber in the configuration of FIG. 3;
FIG. 15 is a schematic cross-sectional view (PCR chamber through) of the fourth body shown in FIG. 3;
FIG. 16 is a schematic cross-sectional view of the fourth body shown in FIG. 3 (PCR chamber not through).
Description of reference numerals:
100. a reagent pack; 110. a sample storage chamber; 120. a lysis storage chamber; 130. a binding liquid storage chamber; 140. A cleaning liquid storage chamber; 150. an eluent storage chamber; 200. a reagent card; 210. a first body; 211. a sample introduction interface; 212. a lysate interface; 213. a first reaction chamber; 213a, a first liquid outlet end; 214. a first air receiving hole; 220. a second body; 221. a second reaction chamber; 221a and a second liquid outlet end; 221b and a second air receiving hole; 222. a binding fluid port; 223. a magnetic particle interface; 224. a cleaning liquid interface; 225. an eluent interface; 226. a waste fluid chamber; 230. a first control valve assembly; 231. a first valve seat; 232. a first valve spool; 232a, a first channel; 232b, a second channel; 240. a storage member; 250. a third body; 251. A lyophilized bead storage chamber; 252. a mixing chamber; 260. a fourth body; 262. a detection chamber; 262a, a PCR cavity; 264. rotating the valve; 270. a second control valve assembly; 271. a second valve seat; 271a, a first through hole; 271b, a second through hole; 271c, a third through hole; 271d, a fourth through hole; 272. a second valve core; 272a, a third channel; 272b, a fourth channel; 272c, a fifth channel; 280. a mixer.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more clearly understood, the present invention will be further described in detail with reference to the accompanying drawings and the following detailed description. It should be understood that the detailed description and specific examples, while indicating the scope of the invention, are intended for purposes of illustration only and are not intended to limit the scope of the invention.
It will be understood that when an element is referred to as being "secured to," "disposed on," "secured to," or "disposed on" another element, it can be directly on the other element or intervening elements may also be present. When an element is referred to as being "connected" to another element, it can be directly connected to the other element or intervening elements may also be present. Further, when one element is "in communication" with another element, the two elements may be in direct communication, or may be in indirect communication via a flow channel, conduit, or the like.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used herein in the description of the invention is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed items.
The terms "first", "second", "third", "fourth", "fifth", "sixth", "seventh", "eighth" and "ninth" used in the present invention do not denote any particular quantity or order, but are merely used to distinguish names.
As shown in fig. 1 and fig. 3, in the present embodiment, a reagent card 200 is provided, which includes a first body 210, the first body 210 includes a sample inlet 211, a lysate inlet 212, a first air receiving hole 214, and a first reaction cavity 213, the sample inlet 211, the lysate inlet, and the first air receiving hole 214 are respectively communicated with the first reaction cavity 213, the first reaction cavity 213 has a first liquid outlet 213a, and the first liquid outlet 213a is staggered with the first air receiving hole 214.
As shown in fig. 1 to 3, when the reagent card 200 is used, the sample inlet 211 is communicated with the reagent pack 100 containing the sample solution, and then the air pump is used to connect the first air inlet 214, so that the sample solution can be pumped into the first reaction chamber 213; the lysis solution interface 212 is connected to the reagent pack 100 containing lysis solution, and the lysis solution can be pumped into the first reaction chamber 213, so that the sample solution can be lysed to obtain a first extract solution (in the process, the lysis of the sample solution can be accelerated by using a heating element or an ultrasonic generator). In the process, manual intervention can be reduced, and the labor intensity of nucleic acid extraction is reduced. And the reagent card 200 is utilized to perform the cracking extraction of the sample liquid, which is beneficial to avoiding the sample liquid from being polluted due to improper manual operation.
It should be noted that the "air pump" may generate a positive pressure thrust and may also generate a negative pressure suction. "pumping" includes suction and pushing.
It can be understood that, after the sample solution is cracked by using the reagent card 200, the first extracting solution can be transferred to the next extracting process manually or automatically through the first liquid outlet.
On the basis of the above embodiments, as shown in fig. 3 to fig. 5, in an embodiment, the reagent card 200 further includes a second body 220, the second body 220 includes a second reaction chamber 221, the second reaction chamber 221 is communicated with the first liquid outlet end 213a, the second reaction chamber 221 is provided with a second gas receiving hole 221b and a second liquid outlet end 221a, and the second liquid outlet end 221a is staggered from the second gas receiving hole 221 b. Thus, the first extract liquid obtained in the first reaction chamber 213 is transferred to the second reaction chamber 221 by generating a negative pressure through the second gas-contacting hole 221b, or the first gas-contacting hole 214 generates a positive pressure to push the first extract liquid into the second reaction chamber 221, so that a subsequent nucleic acid extraction step can be performed in the second reaction chamber 221.
The second body 220 and the first body 210 may be integrally formed, or may be assembled in a module-by-module manner, as long as the first reaction chamber 213 and the second reaction chamber 221 can be communicated with each other.
Based on the above embodiments, as shown in fig. 3, fig. 6 and fig. 7, in an embodiment, the second body 220 further includes a bonding liquid port 222, and the bonding liquid port 222 is communicated with the second reaction chamber 221. Thus, the binding solution can be input into the second reaction chamber 221 through the binding solution interface 222, and then the magnetic particles are input, or the binding solution mixed with the magnetic particles is directly input into the second reaction chamber 221 to be mixed with the first extracting solution, and the effective nucleic acid components in the first extracting solution are adsorbed by the magnetic particles (such as magnetic particles). Further, manual combination operation is not needed, and the labor intensity of nucleic acid extraction is further reduced.
In addition to the above embodiments, as shown in fig. 3, 6 and 7, in one embodiment, the bonding liquid interface 222 is communicated with the second reaction chamber 221 through a first flow channel, and the first flow channel is provided with a magnetic particle interface 223. Then, magnetic particles are introduced into the first flow channel through the magnetic particle interface 223, and the magnetic particles are brought into the second reaction chamber 221 by the binding liquid.
On the basis of the above embodiments, as shown in fig. 1 and fig. 3, in one embodiment, the reagent card 200 further includes a storage component 240 movably connected to the magnetic particle interface 223, the storage component 240 is provided with a storage cavity for storing magnetic particles, and a through hole communicated with the storage cavity; when the storage member 240 is in the first position, the through-hole does not communicate with the first flow channel; when the storage member 240 is in the first position, the through-hole communicates with the first flow passage. Furthermore, the storage part 240 can integrate the magnetic particles into the reagent card 200, which facilitates the operation and further reduces the manual operation steps, so that the nucleic acid extraction is more automated.
On the basis of the above embodiment, as shown in fig. 1, the reagent card further comprises a mixer 280 for stirring the liquid in the second reaction chamber 221. Thus, the magnetic particles and the liquid are uniformly mixed, and the magnetic particles are fully combined with nucleic acid components in the liquid.
The mixer 280 includes, but is not limited to, a reciprocating push-pull rod, an ultrasonic probe, or a gas valve.
In addition to the above embodiments, as shown in fig. 3 and 8, in one embodiment, the second body 220 further includes a cleaning solution interface 224, and the cleaning solution interface 224 is communicated with the second reaction chamber 221. Therefore, the adsorption element can be used for adsorbing the magnetic particles, then the liquid in the second reaction chamber 221 is emptied, then the cleaning liquid is input into the second reaction chamber 221 through the cleaning liquid interface 224, the magnetic particles adsorbed with the biomacromolecule extracts such as nucleic acid and protein are fully washed by the cleaning liquid, and the automatic washing for nucleic acid extraction is completed. Furthermore, manual cleaning operation is not needed, and the labor intensity of nucleic acid extraction is further reduced.
Based on the above embodiments, as shown in fig. 3 and fig. 9, in an embodiment, the second body 220 further includes an eluent interface 225, and the eluent interface 225 is communicated with the second reaction chamber 221. Thus, after the magnetic particles are washed, the magnetic particles are well adsorbed, the liquid in the second reaction cavity 221 is emptied again, the eluent can be input into the second reaction cavity 221 through the eluent interface 225, the magnetic particles are eluted by the eluent, and then a second extracting solution is obtained through incubation; and the manual elution operation is not needed, so that the labor intensity of nucleic acid extraction is further reduced.
On the basis of the above embodiments, as shown in fig. 3 to 10, in an embodiment, the reagent card 200 further includes a first control valve assembly 230, and the first control valve assembly 230 is configured to respectively control on/off of the sample inlet 211 and the first reaction chamber 213, on/off of the lysate interface 212 and the first reaction chamber 213, on/off of the second reaction chamber 221 and the first liquid outlet end 213a, on/off of the second reaction chamber 221 and the binding liquid interface 222, on/off of the second reaction chamber 221 and the cleaning liquid interface 224, and on/off of the second reaction chamber 221 and the eluent interface 225. And then the on-off control of each interface and the corresponding reaction cavity is realized by utilizing the first control assembly.
The first control valve assembly 230 includes, but is not limited to, conventional control valve technology, such as a plurality of on-off valves, that can be applied to the reagent card 200.
In one embodiment, the present application provides a control valve solution that is distinguishable from the prior art. Specifically, as shown in fig. 1, 3 and 10, the first control valve assembly 230 includes a first valve seat 231 and a first valve element 232 movably disposed on the first valve seat 231, the first valve seat 231 is disposed on the first body 210 or/and the second body 220, the first valve seat 231 is respectively communicated with the sample inlet 211, the lysate inlet 212, the binding solution inlet 222, the cleaning solution inlet 224, the eluent inlet 225, the first reaction chamber 213 and the second reaction chamber 221, and the first valve element 232 is provided with a first channel 232a and a second channel 232 b;
as shown in fig. 4 to 9, when the first valve element 232 is in the first position, only the sample inlet 211 communicates with the first reaction chamber 213 through the first channel 232 a; when the first valve core 232 is in the second position, only the lysis buffer interface 212 is communicated with the first reaction chamber 213 through the first channel 232 a; when the first valve core 232 is at the third position, only the second reaction chamber 221 is communicated with the first liquid outlet end 213a through the second channel 232 b; when the first valve core 232 is at the fourth position, only the bonding liquid interface 222 is communicated with the second reaction chamber 221 through the first channel 232 a; when the first valve core 232 is at the fifth position, only the cleaning liquid port 224 is communicated with the second reaction chamber 221 through the first passage 232 a; when the first valve spool 232 is in the sixth position, only the eluent interface 225 communicates with the second reaction chamber 221 through the first passage 232 a. Thus, as shown in fig. 4 to fig. 9, the corresponding on-off control can be realized only by controlling the first valve element 232 to move to different positions, which is beneficial to reducing control valve control elements and simplifying on-off control.
In addition to the above embodiments, as shown in fig. 1 and 9, in one embodiment, the reagent card 200 further includes a second control valve 271, the second control valve 270 has a second valve seat 271 and a second valve core 272 movably disposed in the second valve seat 271, the second valve seat 271 has a first through hole 271a communicating with the first liquid outlet 213a, the binding liquid interface 222, the cleaning liquid interface and the eluent interface, and a second through hole 271b communicating with the second liquid outlet 221a, and the second valve core 272 has a third channel 272a communicating with the first through hole 271a and the second through hole 271 b. Therefore, the second valve spool 272 can be controlled to move to realize corresponding on-off.
Further, as shown in fig. 1, 9 and 10, in an embodiment, the second body 220 further includes a waste liquid chamber 226, the waste liquid chamber 226 is provided with an exhaust hole (not shown), the second valve seat 271 is provided with a third through hole 271c communicated with the waste liquid chamber 226, and the second valve core 272 is provided with a fourth channel 272b for communicating the third through hole 271c with the second through hole 271 b;
when the second spool 272 is in the seventh position, only the first through hole 271a communicates with the second through hole 271b through the third passage 272 a; when the second spool 272 is in the eighth position, only the third through hole 271c communicates with the second through hole 271b through the fourth passage 272 b.
So, like this through setting up waste liquid chamber 226, can concentrate the collection with the waste liquid that the nucleic acid extraction in-process produced, can centralized processing, the pollution abatement. Meanwhile, corresponding on-off control can be realized only by controlling the second valve spool 272 to move to different positions, which is beneficial to reducing control valve control elements and simplifying on-off control.
In addition to the above embodiments, as shown in fig. 1 and 3, in one embodiment, the reagent card 200 further includes a third body 250, the third body 250 is provided with a storage chamber 251 for lyophilized beads and a mixing chamber 252 communicated with the storage chamber 251 for lyophilized beads, the storage chamber 251 for lyophilized beads is communicated with the second outlet 221a, and the mixing chamber 252 is provided with a third air receiving hole (not shown).
So, the third connects the gas pocket to be connected with the air pump, can import freeze-drying bead storage chamber 251 with the second extract to mix the back with freeze-drying bead, shift to mixing chamber 252, the third extract that can obtain accomplishes the extraction of sample liquid nucleic acid. The third extracting solution can be manually transferred to a detection platform after being obtained, and can also be directly used for nucleic acid detection in an in vitro diagnosis analysis device.
Similarly, the third body 250 and the second body 220 or/and the first body 210 may be integrally formed, or may be assembled in a split-module manner by abutting, as long as the mixing cavity 252 and the second reaction cavity 221 can be communicated with each other.
On the basis of the above-described embodiments, as shown in fig. 9 to 13, in one embodiment, the second valve seat 271 is provided with a fourth through hole 271d communicating with the freeze-dried bead storage chamber 251, and the second valve spool 272 is provided with a fifth passage 272c for communicating the fourth through hole 271d with the second through hole 271 b;
when the second spool 272 is in the ninth position, only the fourth passage 271d communicates with the second passage 271b through the fifth passage 272 c.
Further, on/off control between the mixing chamber 252 and the second reaction chamber 221 can be achieved by the second spool 272.
On the basis of the above embodiments, as shown in fig. 1, fig. 11 and fig. 14, in an embodiment, the reagent card 200 further includes a fourth body 260, the fourth body 260 is provided with a detection cavity 262, and the detection cavity 262 is communicated with the liquid outlet end of the mixing cavity 252. The third extract may be further transferred to the detection chamber 262, and then amplified and detected to obtain a detection result. Thus, the detection of nucleic acid can be directly completed, and the detection result of the sample solution can be obtained.
Further, as shown in fig. 15 to 16, in one embodiment, the detection chamber 262 includes four PCR chambers 262a, and the four PCR chambers 262a are connected to the liquid outlet of the mixing chamber 252 through a rotary valve 264. Therefore, the third extracting solution is conveyed to the four PCR cavities 262a by the rotary valve 264, and then the rotary valve 264 is rotated, so that the four PCR cavities 262a are respectively sealed, the problem of cross contamination among the four PCR cavities 262a is avoided, and each PCR cavity 262a can face to different targets, which is beneficial to reducing the dead volume of the eluent. Meanwhile, the optical module is convenient to detect, the optical module has four paths, each time the optical module is aligned to one PCR cavity 262a, only four times of rotation is needed, and the four PCR cavities 262a can be taken care of by using one light path.
Similarly, the fourth body 260 and the third body 250 or/and the second body 220 or/and the first body 210 may be integrally formed, or may be assembled in a split-module manner, as long as the mixing cavity 252 and the second reaction cavity 221 can be communicated with each other.
In this embodiment, the fourth body 260 is integrally formed with the third body 250, the second body 220 and the first body 210.
The specific structures of the sample inlet 211, the lysate inlet 212, the binding solution inlet 222, the cleaning solution inlet 224, and the eluent inlet 225 may be designed correspondingly according to the structure of the reagent pack 100.
In one embodiment, the sample inlet 211, the lysate inlet 212, the binding solution inlet 222, the cleaning solution inlet 224, and the eluent inlet 225 each include a mounting hole and a hollow needle disposed in the mounting hole.
Correspondingly, the reagent pack 100 includes a sample storage chamber 110 for storing a sample solution, a lysis storage chamber 120 for storing a lysis solution, a binding solution storage chamber 130 for storing a binding solution, a cleaning solution storage chamber 140 for storing a cleaning solution, and an eluent storage chamber 150 for storing an eluent. The storage chambers may be inserted into corresponding ports, respectively.
The "first liquid outlet end 213 a" and the "second liquid outlet end 221 a" may also be used for liquid inflow, and are not limited to be used only for liquid outflow.
On the other hand, the present application further provides an in vitro diagnostic and analysis apparatus, which comprises a reagent card 200 and an air pump, wherein the connection end of the air pump is connected with the first air receiving hole 214.
In use, the in vitro diagnostic and analysis apparatus is configured such that the reagent card 200 is connected to the reagent pack 100, and then the reagent card 200 is inserted into a predetermined position. At this time, the air pump is operated to pump the sample solution into the first reaction chamber 213, and the lysis solution is pumped into the first reaction chamber 213 so that the sample solution can be lysed to obtain the first extraction solution. The in vitro diagnosis and analysis device can perform cracking extraction of sample liquid, and is favorable for reducing the labor intensity of nucleic acid extraction.
On the basis of the above embodiments, in one embodiment, the in-vitro diagnostic and analysis apparatus further includes a heating element disposed outside the first reaction chamber 213; or/and an ultrasonic generator, which is disposed outside the first reaction chamber 213. The heating element can be used for heating the liquid in the first reaction chamber 213, so that the sample liquid can be fully cracked; or the ultrasonic generator is arranged outside the first reaction chamber 213, and the ultrasonic generator is used for carrying out ultrasonic treatment on the liquid in the first reaction chamber 213, so that the sample liquid can be fully cracked; or the heating element is used to heat the liquid in the first reaction chamber 213, and then the ultrasonic generator is used to perform ultrasonic treatment on the liquid in the first reaction chamber 213, so that the sample liquid can be fully cracked.
On the basis of the above embodiments, in an embodiment, the in-vitro diagnostic and analysis apparatus further includes an adsorption element, the reagent card 200 is provided with the second reaction chamber 221, the adsorption element is disposed outside the second reaction chamber 221, and the connection end of the air pump can be connected to the second air hole 221 b. Thus, the magnetic particles entering the second reaction chamber 221 can be adsorbed by the adsorption element.
The control method for the liquid flowing in the reagent card 200 may be realized by using an air pump to generate positive pressure or negative pressure according to actual control requirements, so that the liquid reagent card 200 flows at different positions.
The suction element includes, but is not limited to, an electromagnetic element.
The technical features of the above embodiments can be arbitrarily combined, and for the sake of brevity, all possible combinations of the technical features in the above embodiments are not described, but should be considered as the scope of the present specification as long as there is no contradiction between the combinations of the technical features.
The above examples only represent some embodiments of the present invention, and the description thereof is more specific and detailed, but not to be construed as limiting the scope of the present invention. It should be noted that, for those skilled in the art, without departing from the spirit of the present invention, several variations and modifications can be made, which are within the scope of the present invention. Therefore, the protection scope of the present invention should be subject to the appended claims.
Claims (18)
1. The reagent card is characterized by comprising a first body, wherein the first body comprises a sample introduction interface, a lysate interface, a first air receiving hole and a first reaction cavity, the sample introduction interface, the lysate interface and the first air receiving hole are respectively communicated with the first reaction cavity, the first reaction cavity is provided with a first liquid outlet end, and the first liquid outlet end is staggered with the first air receiving hole.
2. The reagent card of claim 1, further comprising a second body, wherein the second body comprises a second reaction chamber, the second reaction chamber is communicated with the first liquid outlet end, the second reaction chamber is provided with a second air receiving hole and a second liquid outlet end, and the second liquid outlet end is staggered with the second air receiving hole.
3. The reagent card of claim 2, wherein the second body further comprises a binding fluid port in communication with the second reaction chamber.
4. The reagent card of claim 3, wherein the binding solution port is communicated with the second reaction chamber through a first flow channel, and the first flow channel is provided with a magnetic particle port.
5. The reagent card of claim 4, further comprising a storage member movably connected to the magnetic particle interface, wherein the storage member is provided with a storage chamber for storing magnetic particles, and a through hole communicated with the storage chamber; when the storage part is at the first position, the through hole is not communicated with the first flow passage; when the storage member is in the second position, the through hole communicates with the first flow passage.
6. The reagent card of claim 4, wherein the second body further comprises a wash solution port in communication with the second reaction chamber.
7. The reagent card of claim 6, wherein the second body further comprises an eluent interface in communication with the second reaction chamber.
8. The reagent card of claim 7, further comprising a first control valve assembly for controlling the connection and disconnection between the sample inlet and the first reaction chamber, the connection and disconnection between the lysate interface and the first reaction chamber, the connection and disconnection between the second reaction chamber and the first liquid outlet end, the connection and disconnection between the second reaction chamber and the binding liquid interface, the connection and disconnection between the second reaction chamber and the cleaning liquid interface, and the connection and disconnection between the second reaction chamber and the eluent interface, respectively.
9. The reagent card of claim 8, wherein the first control valve assembly comprises a first valve seat and a first valve plug movably disposed on the first valve seat, the first valve seat is disposed on the first body or/and the second body, the first valve seat is respectively communicated with the sample inlet, the lysate port, the binding solution port, the cleaning solution port, the eluent port, the first reaction chamber and the second reaction chamber, and the first valve plug is provided with a first channel and a second channel;
when the first valve core is at a first position, only the sample inlet interface is communicated with the first reaction cavity through the first channel;
when the first valve core is at the second position, only the lysate interface is communicated with the first reaction cavity through the first channel;
when the first valve core is at a third position, only the second reaction cavity is communicated with the first liquid outlet end through the second channel;
when the first valve core is at the fourth position, only the bonding liquid interface is communicated with the second reaction cavity through the first channel;
when the first valve core is at a fifth position, only the cleaning liquid interface is communicated with the second reaction cavity through the first channel;
when the first valve core is at the sixth position, only the eluent interface is communicated with the second reaction cavity through the first channel.
10. The reagent card of any one of claims 7 to 9, further comprising a second control valve having a second valve seat and a second valve element movably disposed in the second valve seat, wherein the second valve seat has a first through hole communicating with the first outlet, the binding solution port, the washing solution port and the eluent port, and a second through hole communicating with the second outlet, and the second valve element has a third channel communicating with the first through hole and the second through hole.
11. The reagent card of claim 10, wherein the second body further comprises a waste liquid chamber, the waste liquid chamber is provided with an exhaust hole, the second valve seat is provided with a third through hole communicated with the waste liquid chamber, and the second valve core is provided with a fourth channel for communicating the third through hole and the second through hole;
when the second spool is in a seventh position, only the first through hole communicates with the second through hole through the third passage;
when the second spool is in the eighth position, only the third through-hole communicates with the second through-hole through the fourth passage.
12. The reagent card of claim 11, further comprising a third body, wherein the third body is provided with a freeze-dried bead storage chamber and a mixing chamber communicated with the freeze-dried bead storage chamber, the freeze-dried bead storage chamber is communicated with the second liquid outlet end, and the mixing chamber is provided with a third air receiving hole.
13. The reagent card of claim 12, wherein the second valve seat is provided with a fourth through-hole communicating with the freeze-dried bead storage chamber, and the second valve core is provided with a fifth passage for communicating the fourth through-hole and the second through-hole;
when the second spool is in the ninth position, only the fourth through-hole communicates with the second through-hole through the fifth passage.
14. The reagent card of claim 13, further comprising a fourth body, wherein the fourth body is provided with a detection cavity, and the detection cavity is communicated with the liquid outlet end of the mixing cavity.
15. The reagent card of claim 14, wherein the detection chamber comprises four PCR chambers, and the four PCR chambers are connected to the outlet of the mixing chamber through a rotary valve.
16. An in vitro diagnostic and analytical apparatus, comprising the reagent card of any one of claims 1 to 15, and further comprising an air pump, wherein a connection end of the air pump is connected with the first air receiving hole.
17. The in vitro diagnostic assay device of claim 16, further comprising a heating element disposed outside the first reaction chamber; and the ultrasonic generator is arranged outside the first reaction cavity.
18. The in vitro diagnostic and analytical apparatus according to claim 16 or 17, wherein the reagent card is provided with a second reaction chamber, the second reaction chamber is communicated with the first liquid outlet end, and the second reaction chamber is provided with a second air receiving hole and a second liquid outlet end; the in-vitro diagnosis and analysis device further comprises an adsorption element, the adsorption element is arranged on the outer side of the second reaction cavity, and the connecting end of the air pump can be connected with the second air receiving hole.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201922159498.7U CN211871932U (en) | 2019-12-05 | 2019-12-05 | In-vitro diagnosis and analysis device and reagent card |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201922159498.7U CN211871932U (en) | 2019-12-05 | 2019-12-05 | In-vitro diagnosis and analysis device and reagent card |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN211871932U true CN211871932U (en) | 2020-11-06 |
Family
ID=73244378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201922159498.7U Active CN211871932U (en) | 2019-12-05 | 2019-12-05 | In-vitro diagnosis and analysis device and reagent card |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN211871932U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114405449A (en) * | 2022-02-19 | 2022-04-29 | 鲍熙来 | Chemical experiment device based on micro-fluidic |
-
2019
- 2019-12-05 CN CN201922159498.7U patent/CN211871932U/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114405449A (en) * | 2022-02-19 | 2022-04-29 | 鲍熙来 | Chemical experiment device based on micro-fluidic |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110964715B (en) | In-vitro diagnosis and analysis device and reagent card | |
| CN110964716A (en) | In-vitro diagnosis and analysis device and reagent card | |
| CN105349401B (en) | A kind of multi-functional integrated micro-flow control foranalysis of nucleic acids chip and preparation and analysis method | |
| CN112226361B (en) | Nucleic acid detection card box based on magnetic bead transfer and valve control liquid transfer and detection method | |
| CN207933420U (en) | A kind of micro-fluidic chip of genetic test | |
| CN112844505B (en) | Vertical microfluidic chip and method for nucleic acid extraction and amplification | |
| CN112871230A (en) | Vertical micro-fluidic chip for nucleic acid amplification | |
| CN107723210B (en) | Novel micro-fluidic chip device for nucleic acid detection | |
| CN111909835A (en) | Closed micro-fluidic nucleic acid detection card box | |
| CN114058498B (en) | Full-automatic air microorganism detection system and detection method | |
| CN206375901U (en) | A kind of integrated closed microfluidic nucleic acid detection means | |
| CN113145185A (en) | Modular microfluidic nucleic acid detection chip and system | |
| CN108300640A (en) | A kind of micro-fluidic chip for nucleic acid automation extraction and detection | |
| WO2020107641A1 (en) | Biological reaction device provided with microfluidic or nanofluidic structure | |
| CN211871932U (en) | In-vitro diagnosis and analysis device and reagent card | |
| CN113210024B (en) | Continuous liquid inlet device based on PCR | |
| CN112940922A (en) | Full-integrated pathogen nucleic acid detection micro-fluidic chip | |
| CN110452806A (en) | The micro-fluidic nucleic acid detection chip of full-automation, its kit and method based on ring mediated isothermal amplification | |
| CN109890505A (en) | Microfluidic device and method for analyzing nucleic acid | |
| CN114015567A (en) | Pneumatic integrated PCR detection kit based on rotary plunger and detection method thereof | |
| CN111534575A (en) | Microfluidic nucleic acid detection card box and kit | |
| CN114182000B (en) | CRISPR technology-based integrated nucleic acid detection chip and method | |
| CN214571848U (en) | Vertical micro-fluidic chip that nucleic acid drawed usefulness | |
| CN214599114U (en) | Vertical micro-fluidic chip for nucleic acid amplification | |
| CN214553637U (en) | Vertical micro-fluidic chip for extracting and amplifying nucleic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |